SavedAdd your journal

Journals / European Journal of Therapeutics / 2013 / Cilt: 19 Sayı: 1

Relation of left atrial volume index with subclinical atherosclerosis at patients with metabolic syndrome

Metabolik sendromlu hastalarda sol atriyal volüm indeksi'nin subklinik ateroskleroz ile ilişkisi 3,4, 3,

Ali Rıza GÜLCAN
Mustafa Serkan KARAKAŞ
Refik Emre ALTEKİN
Sinan Cemgil ÖZBEK
Barış AKDEMİR
Hüseyin YILMAZ
Pages
5–12
Publication Date
2013-02-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients were divided into 2 groups according to CIMT measurement: 35 patients with CIMT≥1.0 mm were at group 1 and 47 patients with CIMT

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Metabolic syndrome (MetS) increases the frequency of cardivovascular events by causing atherosclerosis and impairment at left ventricle structure and function.
📊
Key Findings & Data:With this study, we investigated the relationship between subclinical atherosclerosis ,evaluated by carotid intima-media thickness (CIMT) measurement and subclinical cardiac injury evaluated by diastolic functions and left atrial volume index (LAVI) in MetS patients. 82 patients with MetS were enrolled to the study.
💡
Conclusion & Impact:Patients were divided into 2 groups according to CIMT measurement: 35 patients with CIMT≥1.0 mm were at group 1 and 47 patients with CIMT
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diyastolik disfonksiyon · karotis intima-media kalınlığı · metabolik sendrom

Abstract

Metabolic syndrome (MetS) increases the frequency of cardivovascular events by causing atherosclerosis and impairment at left ventricle structure and function. Diastolic dysfunction (DD) is an early finding of subclinical cardiac injury. Left atrial volume may be used as an indicator for demonstrating severity and duration of DD. With this study, we investigated the relationship between subclinical atherosclerosis ,evaluated by carotid intima-media thickness (CIMT) measurement and subclinical cardiac injury evaluated by diastolic functions and left atrial volume index (LAVI) in MetS patients. 82 patients with MetS were enrolled to the study. Patients were divided into 2 groups according to CIMT measurement: 35 patients with CIMT≥1.0 mm were at group 1 and 47 patients with CIMT

Özet

Metabolik sendrom (MetS) ateroskleroza, sol ventrikül yapı ve fonksiyonlarında bozulmaya neden olur. Diyastolik disfonksiyon (DD) subklinik kardiyak hasarın erken dönem bulgusudur. Sol atriyal volüm DD'un ciddiyetini ve süresini göstermede bir belirteç olarak kullanılabilir. Çalışmamızda, MetS'lu hastalarda sol ventrikül DD ve derecesini, sol atriyal volüm indeksi (SAVİ) ile birlikte değerlendirdik ve bunun karotis intima media kalınlığı (KİMK) ile tespit edilen subklinik aterosklerozla ilişkisini araştırdık. Çalışmaya MetS'lu 82 hasta alındı. Hastalar KİMK ölçümüne göre, KİMK≥1,0 mm olan 35 hasta grup 1, KİMK

🔖

Cite This Article

GÜLCAN, A. R., KARAKAŞ, M. S., ALTEKİN, R. E., ÖZBEK, S. C., AKDEMİR, B., YILMAZ, H. (2013). Relation of left atrial volume index with subclinical atherosclerosis at patients with metabolic syndrome. European Journal of Therapeutics, Cilt: 19 Sayı: 1, 5–12. https://ajindex.com/articles/976910

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Gören B, Fen T. Metabolik Sendrom. Türkiye Klinikleri J Med Sci 2008;28(5):686-96.
  2. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and metaanalysis of longitudinal studies. J Am Coll Cardiol 2007;49(4):403-14
  3. Roes SD, Alizadeh Dehnavi R, Westenberg JJ, Lamb HJ, Mertens BJ, Tamsma JT, et al. Assessment of aortic pulse wave velocity and cardiac diastolic function in subjects with and without the metabolic syndrome: HDL cholesterol is independently associated with cardiovascular function. Diabetes Care 2008;31(7):1442-4. von Bibra H, St John Sutton M. Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 2010;53(6):1033-45.
  4. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004;25(4):543-67
  5. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42(7):1149-60.
  6. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophsiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007;58(5):513-22.
  7. Sinha AK, Eigenbrodt M, Mehta JL. Does carotid intima media thickness indicate coronary atherosclerosis? Curr Opin Cardiol 2002;17(5):526-30.
  8. Leung DY, Chi C, Allman C, Boyd A, Ng AC, Kadappu KK, et al. Prognostic implications of left atrial volume index in patients in sinus rhythm. Am J Cardiol 2010;105(11):1635-9. http://www.idf.org/webdata/docs/IDF_Metasyndrome_def.pdf (Erişim tarihi 04.10.2005).
  9. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1997;55(4):613-8.
  10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18(12):1440-63.
  11. Leung DY, Boyd A, Ng AA, Chi C, Thomas L. Echocardiographic evaluation of left atrial size and function: current